Article ID Journal Published Year Pages File Type
3282627 Clinical Gastroenterology and Hepatology 2013 12 Pages PDF
Abstract
For patients with short-bowel syndrome intestinal failure, the efficacy of teduglutide was maintained over 52 weeks and the safety profile was sufficient for it to be considered for long-term use. Further studies are needed to determine whether these effects will translate into improved quality of life and reduced PN complications. ClinicalTrials.gov number, NCT00172185.
Related Topics
Health Sciences Medicine and Dentistry Gastroenterology
Authors
, , , , , ,